A detailed history of Legacy Financial Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 13,556 shares of NVO stock, worth $1.18 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
13,556
Previous 13,492 0.47%
Holding current value
$1.18 Million
Previous $1.93 Million 16.16%
% of portfolio
0.31%
Previous 0.38%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $7,620 - $9,306
64 Added 0.47%
13,556 $1.61 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $94,732 - $113,414
772 Added 6.07%
13,492 $1.93 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $70,966 - $94,464
695 Added 5.78%
12,720 $1.63 Million
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $122,277 - $146,891
1,393 Added 13.1%
12,025 $1.24 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $531,453 - $1.17 Million
5,844 Added 122.06%
10,632 $966,000
Q2 2023

Aug 08, 2023

SELL
$155.98 - $172.65 $41,802 - $46,270
-268 Reduced 5.3%
4,788 $774,000
Q1 2023

May 03, 2023

BUY
$132.34 - $159.14 $83,903 - $100,894
634 Added 14.34%
5,056 $804,000
Q4 2022

Feb 06, 2023

BUY
$102.55 - $135.33 $7,178 - $9,473
70 Added 1.61%
4,422 $598,000
Q3 2022

Nov 09, 2022

BUY
$95.28 - $116.93 $50,688 - $62,206
532 Added 13.93%
4,352 $434,000
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $32,933 - $38,857
319 Added 9.11%
3,820 $426,000
Q1 2022

May 04, 2022

BUY
$93.1 - $112.54 $10,613 - $12,829
114 Added 3.37%
3,501 $389,000
Q4 2021

Feb 04, 2022

BUY
$95.88 - $117.08 $37,584 - $45,895
392 Added 13.09%
3,387 $379,000
Q3 2021

Oct 26, 2021

BUY
$84.42 - $106.62 $50,905 - $64,291
603 Added 25.21%
2,995 $288,000
Q2 2021

Jul 21, 2021

BUY
$67.66 - $84.76 $161,842 - $202,745
2,392 New
2,392 $200,000
Q2 2019

Aug 07, 2019

SELL
$46.79 - $52.47 $130,076 - $145,866
-2,780 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$46.36 - $52.63 $53,360 - $60,577
-1,151 Reduced 29.28%
2,780 $145,000
Q4 2018

Jan 16, 2019

BUY
$41.54 - $47.25 $1,869 - $2,126
45 Added 1.16%
3,931 $181,000
Q3 2018

Oct 30, 2018

BUY
$46.76 - $51.24 $152,764 - $167,401
3,267 Added 527.79%
3,886 $183,000
Q2 2018

Jul 17, 2018

SELL
$44.29 - $50.42 $3,853 - $4,386
-87 Reduced 12.32%
619 $31,000
Q1 2018

Apr 12, 2018

SELL
$48.49 - $58.14 $11,928 - $14,302
-246 Reduced 25.84%
706 $35,000
Q4 2017

Feb 09, 2018

BUY
$47.53 - $53.73 $45,248 - $51,150
952
952 $51,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Legacy Financial Advisors, Inc. Portfolio

Follow Legacy Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.